Found: 28
Select item for more details and to access through your institution.
Corrigendum: Association of Platelet Thromboxane Inhibition by Low‐Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 5, p. 1161, doi. 10.1002/cpt.2893
- Publication type:
- Article
Erratum: Abstracts of Papers, 2023 Annual Meeting.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 5, p. 1160, doi. 10.1002/cpt.2892
- Publication type:
- Article
Highlights.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 5, p. 948, doi. 10.1002/cpt.2884
- Publication type:
- Article
Biomarkers Come of Age in Clinical Pharmacology.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 5, p. 945, doi. 10.1002/cpt.2880
- By:
- Publication type:
- Article
In This Issue.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 5, p. 943, doi. 10.1002/cpt.2879
- Publication type:
- Article
ASCPT News.
- Published in:
- 2023
- Publication type:
- Proceeding
The Association Between Baseline Hepatic or Renal Function and Clinical Outcomes for Patients With Non‐Small Cell Lung Cancer Treated With a PD‐1/PD‐L1 Blocking Antibody Using Real‐World and Trial Data.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 5, p. 1139, doi. 10.1002/cpt.2874
- By:
- Publication type:
- Article
Warfarin‐Rifampin‐Gene (WARIF‐G) Interaction: A Retrospective, Genetic, Case–Control Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 5, p. 1150, doi. 10.1002/cpt.2871
- By:
- Publication type:
- Article
Development and Bioequivalence of 3D‐Printed Medication at the Point‐of‐Care: Bridging the Gap Toward Personalized Medicine.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 5, p. 1125, doi. 10.1002/cpt.2870
- By:
- Publication type:
- Article
Generating the Right Evidence at the Right Time: Principles of a New Class of Flexible Augmented Clinical Trial Designs.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 5, p. 1132, doi. 10.1002/cpt.2869
- By:
- Publication type:
- Article
Estimating Culprit Drugs for Adverse Drug Reactions Based on Bayesian Inference.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 5, p. 1117, doi. 10.1002/cpt.2867
- By:
- Publication type:
- Article
COVID‐19 Vaccination and the Incidence of De Novo or Recurrent Rheumatoid Arthritis: A French and International (VigiBase) Signal Detection Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 5, p. 1107, doi. 10.1002/cpt.2866
- By:
- Publication type:
- Article
Kinetics of Circulating Extracellular Vesicles Over the 24‐Hour Dosing Interval After Low‐Dose Aspirin Administration in Patients at Cardiovascular Risk.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 5, p. 1096, doi. 10.1002/cpt.2865
- By:
- Publication type:
- Article
Genetic Variants Associated With Opioid Use Disorder.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 5, p. 1089, doi. 10.1002/cpt.2864
- By:
- Publication type:
- Article
Oral Oxycodone‐Induced Respiratory Depression During Normocapnia and Hypercapnia: A Pharmacokinetic‐Pharmacodynamic Modeling Study.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 5, p. 1080, doi. 10.1002/cpt.2863
- By:
- Publication type:
- Article
N<sup>1</sup>‐Methylnicotinamide as Biomarker for MATE‐Mediated Renal Drug–Drug Interactions: Impact of Cimetidine, Rifampin, Verapamil, and Probenecid.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 5, p. 1070, doi. 10.1002/cpt.2849
- By:
- Publication type:
- Article
Effect of Hepatic Impairment on OATP1B Activity: Quantitative Pharmacokinetic Analysis of Endogenous Biomarker and Substrate Drugs.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 5, p. 1058, doi. 10.1002/cpt.2829
- By:
- Publication type:
- Article
Beyond the Michaelis–Menten: Accurate Prediction of Drug Interactions Through Cytochrome P450 3A4 Induction.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 5, p. 1048, doi. 10.1002/cpt.2824
- By:
- Publication type:
- Article
Development of Therapeutic Proteins for a New Subcutaneous Route of Administration After the Establishment of Intravenous Dosages: A Systematic Review.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 5, p. 1011, doi. 10.1002/cpt.2823
- By:
- Publication type:
- Article
Pharmacodynamic Biomarkers for Biosimilar Development and Approval: A Workshop Summary.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 5, p. 1030, doi. 10.1002/cpt.2795
- By:
- Publication type:
- Article
How to Run the Pharmacogenomics Clinical Annotation Tool (PharmCAT).
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 5, p. 1036, doi. 10.1002/cpt.2790
- By:
- Publication type:
- Article
Japanese Pharmaceutical Regulations of Engineered Viral Vectors for Medical Use Compared With Those in the United States and the European Union.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 5, p. 960, doi. 10.1002/cpt.2788
- By:
- Publication type:
- Article
The Mannose in the Mirror: A Reflection on the Pharmacokinetic Impact of High Mannose Glycans of Monoclonal Antibodies in Biosimilar Development.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 5, p. 1003, doi. 10.1002/cpt.2783
- By:
- Publication type:
- Article
From Cold to Hot: Changing Perceptions and Future Opportunities for Quantitative Systems Pharmacology Modeling in Cancer Immunotherapy.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 5, p. 963, doi. 10.1002/cpt.2770
- By:
- Publication type:
- Article
Fine‐Tuning the Relevance of Molecular Targets to Pediatric Cancer: Addressing Additional Layers of Complexity.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 5, p. 957, doi. 10.1002/cpt.2759
- By:
- Publication type:
- Article
Expanded Clinical Pharmacogenetics Implementation Consortium Guideline for Medication Use in the Context of G6PD Genotype.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 5, p. 973, doi. 10.1002/cpt.2735
- By:
- Publication type:
- Article
Reimagining the Framework Supporting the Static Analysis of Transporter Drug Interaction Risk; Integrated Use of Biomarkers to Generate Pan‐Transporter Inhibition Signatures.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 5, p. 986, doi. 10.1002/cpt.2713
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology & Therapeutics, 2023, v. 113, n. 5, p. 935, doi. 10.1002/cpt.2657
- Publication type:
- Article